Chopra Sapna, Kaur Paramjit, Bedi Ravneet Kaur, Kaur Gagandeep
All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Government Medical College and Hospital, Sector 32, Chandigarh, India.
Hematol Transfus Cell Ther. 2023 Jan-Mar;45(1):16-24. doi: 10.1016/j.htct.2021.05.002. Epub 2021 Jun 18.
The demand for apheresis platelets has increased in the recent past and the shrinking donor pool has shifted the trend to collection of double-dose or higher yield of platelets.
The present study aimed to determine the effect of double-dose plateletpheresis on the target yield and donor platelet recovery.
The study was conducted on 100 healthy plateletpheresis donors, 50 of whom were in the study group, which underwent double-dose plateletpheresis (DDP), and 50 of whom were in the control group for single-donor plateletpheresis. Pre- and post-procedure samples of donors were subjected to a complete blood count. The DDP product was sampled for platelet yield and then split into two parts. Platelet yield, collection efficiency, collection rate, recruitment factor and donor platelet loss were calculated.
The mean platelet yield in the SDP was 4.09 ± 1.15 × 10 and in the DDP, 5.93 ± 1.04 × 10. There was a significant correlation between the pre-donation platelet count and platelet yield. The total of platelets processed for the SDP were 5.42 ± 1.08 × 10 and for the DDP, 7.94 ± 0.77 × 10. The collection efficiency was 71.93 ± 25.14% in the SDP and 72.94 ± 16.28% in the DDP, while the collection rates were 0.78 × 10 and 0.94 × 10 per minute, respectively. The average recruitment factor observed was 0.98 in the SDP, while it was 0.99 in the DDP. The mean platelet loss observed in the SDP was 35.55 ± 8.53% and in the DDP, 37.76 ± 8.65%.
The double-dose plateletpheresis supplements the platelet inventory in developing countries where the apheresis donor pool is limited. It is prudent to ensure stringent donor selection criteria for donors donating high-yield platelet products, thus enhancing donor safety and retention.
近年来,单采血小板的需求有所增加,而献血者群体的萎缩使得采集双倍剂量或更高产量血小板的趋势有所转变。
本研究旨在确定双倍剂量血小板单采对目标产量和献血者血小板回收率的影响。
对100名健康的血小板单采献血者进行了研究,其中50名在研究组,接受双倍剂量血小板单采(DDP),另外50名在对照组,进行单采血小板。在采血前后对献血者的样本进行全血细胞计数。对DDP产品进行血小板产量采样,然后分成两部分。计算血小板产量、采集效率、采集率、招募因子和献血者血小板损失。
单采血小板(SDP)的平均血小板产量为4.09±1.15×10,而在DDP中为5.93±1.04×10。献血前血小板计数与血小板产量之间存在显著相关性。SDP处理的血小板总数为5.42±1.08×10,DDP为7.94±0.77×10。SDP的采集效率为71.93±25.14%,DDP为72.94±16.28%,而采集率分别为每分钟0.78×10和0.94×10。在SDP中观察到的平均招募因子为0.98,而在DDP中为0.99。在SDP中观察到的平均血小板损失为35.55±8.53%,在DDP中为37.76±8.65%。
在单采献血者群体有限的发展中国家,双倍剂量血小板单采补充了血小板库存。对于捐献高产血小板产品的献血者,确保严格的献血者选择标准是谨慎的做法,从而提高献血者安全性和保留率。